Should You Add Reata Pharmaceuticals (RETA) to Your Portfolio?
TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” second-quarter investor letter.
Posts Tagged ‘NASDAQ:RETA’
5 Best-Performing Stocks in the Last 12 Months
In this article, we will take a look at the 5 best-performing stocks in the last 12 months.
15 Best Performing Stocks in the Last 3 Months
In this article, we discuss 15 best performing stocks in the last 3 months.
5 Best Performing Stocks in the Last 6 Months
In this article, we discuss 5 best performing stocks in the last 6 months.
12 Under-the-Radar Stocks That Are on The Move
In this article, we discuss 12 under-the-radar stocks that are on the move.
15 Best NASDAQ Stocks To Buy Today
In this piece, we will take a look at 15 best NASDAQ stocks to buy today.
10 Under-the-Radar Stocks Billionaires Are Loading Up On
In this article, we discuss 10 under-the-radar stocks billionaires are loading up on.
Reata Pharmaceuticals, Inc. (NASDAQ:RETA) Q1 2023 Earnings Call Transcript
Operator: Thank you for standing by, and welcome to the Reata Pharmaceuticals First Quarter Financial Results Update on Operational Progress and Development Programs Conference...
Reata Pharmaceuticals, Inc. (NASDAQ:RETA) Q3 2022 Earnings Call Transcript
Operator: Thank you for standing by, and welcome to the Reata Pharmaceuticals Third Quarter 2022 Financial Results and Update on Development Programs Conference Call.
15 Most Shorted Stocks Hedge Funds Are Buying
In this article, we will discuss the 15 most shorted stocks hedge funds are buying.
5 Healthcare Stocks to Invest In Today According to Stanley Druckenmiller
In this piece, we will take a look at the five healthcare stocks to invest in today according to Stanley Druckenmiller.
Hedge Fund and Insider Trading News: Ray Dalio, Alan Howard, Ken Griffin, SW Capital, Reata Pharmaceuticals Inc (RETA), ANSYS, Inc. (ANSS), and More
Livepeer, an Ethereum-based network that helps startups add live and on-demand video to their products, has raised $20 million in a Series B extension funding round with backing...
Stanley Druckenmiller is Selling These 12 Stocks
In this article, we discuss the 12 stocks Stanley Druckenmiller is selling.
Is Reata Pharmaceuticals, Inc. (RETA) A Good Stock To Buy?
After several tireless days we have finished crunching the numbers from nearly 900 13F filings issued by the elite hedge funds and other investment firms that we track at Insider...
Is RETA Stock A Buy or Sell?
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
Were Hedge Funds Wrong About Reata Pharmaceuticals, Inc. (RETA)?
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (Recession is Imminent: We...
Hedge Funds Can’t Stop Buying Reata Pharmaceuticals, Inc. (RETA)
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy...
Did Hedge Funds Make The Right Call On Reata Pharmaceuticals, Inc. (RETA) ?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Hedge Funds Aren’t Done Buying Reata Pharmaceuticals, Inc. (RETA)
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the...
Hedge Funds Have Never Been This Bullish On Reata Pharmaceuticals, Inc. (RETA)
We hate to say this but, we told you so.
Hedge Funds Have Never Been This Bullish On Reata Pharmaceuticals, Inc. (RETA)
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Reata Pharmaceuticals, Inc. (RETA): These Hedge Funds Sold Prior To Large Gains
Concerns over rising interest rates and expected further rate increases have hit several stocks hard during the fourth quarter of 2018.
Hedge Fund and Insider Trading News: Bill Ackman, Ray Dalio, Highland Capital Management, Reata Pharmaceuticals Inc (RETA), Ulta Beauty Inc. (ULTA), and More
Bill Ackman’s Pershing Square Capital Management disclosed that it again trimmed its investment in Chipotle Mexican Grill stock.
Hedge Funds Have Never Been This Bullish On Reata Pharmaceuticals, Inc. (RETA)
The government requires hedge funds and wealthy investors that crossed the $100 million equity holdings threshold are required to file a report that shows their positions at the...
Did Hedge Funds Drop The Ball On Reata Pharmaceuticals, Inc. (RETA) ?
Hedge funds and large money managers usually invest with a focus on the long-term horizon and, therefore, short-lived dips on the charts, usually don't make them change their ...
Reata Pharmaceuticals, Inc. (RETA): Hedge Funds Are Snapping Up
Insider Monkey has processed numerous 13F filings of hedge funds and famous investors to create an extensive database of hedge fund holdings.
Reata Pharmaceuticals Inc (RETA) Puts Out Positive PAH Data – What’s Next?
Reata Pharmaceuticals Inc (NASDAQ:RETA) just announced data from an interim study of its lead blood pressure study, and they company has picked up a bit of strength on the back...
